Unique ID issued by UMIN | UMIN000051443 |
---|---|
Receipt number | R000056488 |
Scientific Title | Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease. |
Date of disclosure of the study information | 2023/07/01 |
Last modified on | 2024/01/13 14:00:07 |
Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease - Evaluation Study for MRI Utilization -.
Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease.
Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease.
Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease.
Japan |
Chronic Kidney Disease
Nephrology |
Others
NO
Development of clinical indicators that can be used to evaluate the pathophysiology of patients with chronic kidney disease.
Others
1) Evaluation of renal morphology and physiological parameters by magnetic resonance imaging
2) Evaluation of target molecule concentrations in blood and urine
Results of blood and urine biomarkers and magnetic resonance imaging.
Observational
18 | years-old | <= |
Not applicable |
Male and Female
Patients with chronic kidney disease who are attending the Department of Nephrology at Saitama Medical University Hospital approximately every 1-2 months and who have indicated their willingness to consent to the study after receiving a written explanation.
(1) Patients deemed inappropriate by the principal investigator
(e.g., after introduction of renal replacement therapy, children (under 18 years old), acute kidney injury, unilateral renal disease (e.g., renal vascular hypertension), renal tumor, severe edematous disease (e.g., nephrotic syndrome), cystic disease, postrenal kidney disease)
(2) Patients who have changed the content of the given medication in the initial entry
(At the time of the change in the content of the medication because the purpose is to confirm the baseline [MRI, biomarkers] of the case.)
(3) Those whose MRI images or laboratory test results are deemed inappropriate for evaluation
(When the renal parenchyma is poorly delineated on MRI due to artifacts from body movement, atrophy, cysts, scarring, etc., or when the specimen acquisition and processing process is inappropriate and is inferred not to reflect the pathophysiology of the subject)
25
1st name | Hirokazu |
Middle name | |
Last name | Okada |
Saitama Medical University
Nephrology
350-0495
38 Morohongo Moroyama-machi Iruma-gun Saitama Japan
049-276-1611
hirookda@saitama-med.ac.jp
1st name | Hirokazu |
Middle name | |
Last name | Okada |
Saitama Medical University
Nephrology
350-0495
38 Morohongo Moroyama-machi Iruma-gun Saitama Japan
049-276-1611
hirookda@saitama-med.ac.jp
Saitama Medical University
CHUGAI PHARMACEUTICAL CO.,LTD
Profit organization
Saitama Medical University
38 Morohongo Moroyama-machi Iruma-gun Saitama Japan
049-276-1354
hirb@saitama-med.ac.jp
NO
2023 | Year | 07 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2022 | Year | 12 | Month | 13 | Day |
2023 | Year | 07 | Month | 15 | Day |
2023 | Year | 07 | Month | 01 | Day |
2025 | Year | 08 | Month | 31 | Day |
This study aims to develop clinical indices for chronic kidney disease (CKD) through analysis of renal MRI and blood and urine biomarkers that can be used to understand the pathophysiology of CKD patients and to evaluate new drugs. This is an exploratory (noninterventional) observational clinical study.
2023 | Year | 06 | Month | 24 | Day |
2024 | Year | 01 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056488
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |